For the investigational use of Adipose Derived
Stem Cells (ADSC's) for clinical research and deployment.
ILAR J. 2009; 51(1) : 24-41. Preclinical assessment of stem cell therapies for neurological diseases. Joers VL, Emborg ME. Neuroscience Training Program, University of Wisconsin, Madison, WI, USA. Abstract Stem cells, as subjects of study for use in treating neurological diseases, are envisioned as a replacement for lost neurons and glia, a means of trophic…
Stem Cells. 2009 Nov; 27(11) : 2846-56. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule. Ourednik V, Ourednik J, Xu Y, Zhang Y, Lynch WP, Snyder EY, Schachner M. Department of Biomedical Sciences, VetMed, Iowa State University, Ames, Iowa, USA. Abstract In the injured…
Int J Pharm. 2009 Nov 3; 381(2) : 113-21. Epub 2009 Mar 19. Pluripotent stem cells as new drugs? The example of Parkinson’s disease. Preynat-Seauve O, Burkhard PR, Villard J, Zingg W, Ginovart N, Feki A, Dubois-Dauphin M, Hurst SA, Mauron A, Jaconi M, Krause KH. Department of Genetic and Laboratory Medicine, Geneva University Hospitals,…
Neurosurgery. 2009 Oct; 65(4) : 741-53; discussion 753. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain. Mine Y, Hayashi T, Yamada M, Okano H, Kawase T. Department of Neurosurgery, School of Medicine, Keio University, Tokyo, Japan. Erratum in: Neurosurgery. 2009 Dec;65(6):1062. Abstract OBJECTIVE: To physiologically repair damaged…
Sci China C Life Sci. 2009 Jul; 52(7) : 610-4. Epub 2009 Jul 30. Cells therapy for Parkinson’s disease–so close and so far away. Ren Z, Zhang Y. Cell Therapy Center, Xuanwu Hospital, Capital Medical University and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing, 100053, China. Abstract One of the strategies of treating Parkinson’s…
Biochim Biophys Acta. 2009 Jul; 1792(7) : 688-702. Epub 2008 Oct 25. Cell replacement therapy for Parkinson’s disease. Wijeyekoon R, Barker RA. Cambridge Centre for Brain Repair, Forvie Site, Cambridge, UK. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder in which the degeneration of dopaminergic neurons projecting from the substantia nigra to the striatum…
Cell Tissue Res. 2008 Jan; 331(1) : 301-22. Epub 2007 Sep 28. Human stem cells for CNS repair. Zietlow R, Lane EL, Dunnett SB, Rosser AE. Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, CF10 3US, UK. zietlowr@cf.ac.uk Abstract Although most peripheral tissues have at least a limited ability for self-repair, the central nervous…
Neurosurg Focus. 2008; 24(3-4) : E11. Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders. Yu D, Silva GA. Department of Bioengineering, University of California, San Diego, USA. Abstract In the past decades, stem cell biology has made a profound impact on our views of mammalian development as well as…
J Neuroimmune Pharmacol. 2007 Sep; 2(3) : 243-50. Epub 2007 May 9. Stem cell transplantation: a promising therapy for Parkinson’s disease. Wang Y, Chen S, Yang D, Le WD. Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Science and Shanghai Jiao Tong University School of Medicine, 225# South Chongqing Road,…
Ann Med. 2005; 37(7) : 487-98. Stem cell-based therapy for Parkinson’s disease. Correia AS, Anisimov SV, Li JY, Brundin P. Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden. Sofia.Correia@med.lu.se Abstract Motor dysfunctions in Parkinson’s disease are considered to be primarily due to the degeneration of dopaminergic neurons in…
